Type 1 Diabetes 2017
Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.
Adapting open-loop settings that are used by the artificial pancreas algorithm is easily understandable and transparent to both patients and physicians.
Real-time continuous glucose monitoring systems are comparable to traditional blood glucose monitoring methods in preterm infants.
With this statement, researchers hope to improve safety and efficacy outcomes, advance technology, and improve patient quality of life and health outcomes.
Although the incidence of severe hypoglycemia has decreased while insulin pump use has increased, a causal relationship has not been established between insulin administration methods and risk of complications from diabetes.
Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.
Peptide immunotherapy may offer a personalized approach to modulating the immune response in persons with type 1 diabetes.
New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.
Data from a phase 1 study was presented at the 2017 ADA Scientific Sessions.
Although metformin did not improve glycemic control in patients with type 1 diabetes, the treatment did improve cardiovascular disease risk management.
Both mealtime and postmeal faster insulin aspart are noninferior to mealtime conventional insulin aspart, regarding HbA1c change from baseline.
After 3 days without taking insulin, a patient presents to the emergency room with hyperglycemia and concerns of diabetic ketoacidosis.
There is a 5% probability of progression from state 1 to state 5 between retinal screenings.
Adjuvant metformin produced a small but nonsignificant decrease in body mass index and insulin dose, but by year 10, no beneficial effects were evident.
The studies will assess the safety, efficacy, and user-friendliness among other aspects, of multiple artificial pancreas devices.
Exercise management for patients with type 1 diabetes should be individualized, depending on insulin concentrations and exercise type/intensity.
Patients with type 1 diabetes who used multiple insulin injections daily experienced reductions in HbA1c with continuous glucose monitoring.
The use of hydrolyzed vs nonhydrolyzed cow's milk-based infant formula does not appear to reduce risk for islet autoimmunity.
People with type 1 diabetes have specific changes in gut bacteria and inflammation of the digestive tract compared with people without the disease.
A recent study confirms that frequent enterovirus infection may contribute to the development of type 1 diabetes in children.
Endocrinology Advisor Articles
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Dulaglutide Effective for Patients With T2D, Moderate to Severe CKD
- Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment
- Guidelines for Management of Hypothalamic-Pituitary, Growth Disorders in Childhood Cancer Survivors
- Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- New Romosozumab BLA Includes Data from Additional Osteoporosis Trials
- Impact of Maternal Diabetes on Outcomes in Very Preterm, Very Low-Birth-Weight Infants
- Age-Related Differences in Manifestation of Cushing Disease Identified
- International Group Develops Best Practices for Drug Packaging